Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-30
1995-02-14
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514422, 514456, 514457, A61K 31445, A61K 3140, A61K 3135
Patent
active
053896467
ABSTRACT:
Methods and pharmaceutical compositions for reducing bone loss are disclosed. 2,3-diaryl-1-benzopyrans and their pharmaceutically acceptable salts are formulated into medicaments for the treatment of bone loss due to osteoporosis or other conditions. Formulations include tablets and other forms suitable for oral administration and controlled-release subdermal implants.
REFERENCES:
patent: 3471520 (1969-10-01), Irmscher et al.
patent: 4210644 (1980-07-01), Ewing et al.
patent: 4489056 (1984-12-01), Himmelstein et al.
patent: 4644012 (1987-02-01), Tsuda et al.
patent: 5254568 (1993-10-01), Kapil et al.
patent: 5280040 (1994-01-01), Labroo et al.
Broulik, Endocrin. Reg. 25: 217-219, 1991.
Saeed et al., J. Med. Chem. 33: 3210-3216, 1990.
Sharma et al., J. Med. Chem. 33: 3216-3222, 1990.
Sharma et al., J. Med. Chem. 33: 3222-3229, 1990.
Ray et al., J. Med. Chem. 19: 276-279, 1976.
Cintins Marianne M.
Criares T. J.
Parker Gary E.
ZymoGenetics Inc.
LandOfFree
Methods for treatment and prevention of bone loss using 2,3-benz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treatment and prevention of bone loss using 2,3-benz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment and prevention of bone loss using 2,3-benz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-288346